A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma

作者：Wang Qu, Cheng Fu, Weiqing Han, Hong Luo, Jizhong Quan, Lijun Chen, Yong Liao, Chang-Lu Hu, Hailong Hu, Yinong Niu, Danfeng Xu, Minfeng Chen, Jimin Chen, Yongda Liu, Guojun Chen, Zhanxiong Luo, Benkang Shi, Yongkun Sun, Fangjian Zhou, Aiping Zhou · 发表于：European Journal of Cancer · 年份：2024 · DOI：10.1016/j.ejca.2024.114096 · 被引用次数：11 · 研究领域：Bladder and Urothelial Cancer Treatments、HER2/EGFR in Cancer Research、Cancer Cells and Metastasis